One Nucleus Boston Bootcamp 2024

Sponsored by:


Over recent months, One Nucleus has developed an increasingly closer relationship with key contacts within the Massachusetts Life Science Cluster as it seeks to build an effective bridge between the One Nucleus members and the World’s number one location for our sector.  

Outputs from the BIO International Convention 2023 satellite breakfast highlighted some key messages:

  • There was potential to capitalise on the existing B2B activity being undertaken to increase two-way deal flow further.
  • There were significant knowledge gaps for emerging UK companies in how to navigate the MA cluster to seek support, collaborations and deals.
  • There was lack of articulated value proposition around the relationship.
  • Whilst there exists a number of ecosystem-to-ecosystem initiatives, there was apparent benefit to more targeted interventions.

For this reason, One Nucleus is pleased to announce the launch of the inaugural Boston Bootcamp, aimed at UK companies looking to expand into the MA cluster.

The Prize:

  • Participation in the 3-day bootcamp programme
  • Return Premium Economy flights LHR-BOS
  • 3 nights hotel accommodation
  • Participation in pre-bootcamp preparatory sessions led by life science experts with experience of Greater Boston 
  • Free delegate place at the One Nucleus Annual Awards Dinner
  • Free speaker place at ON Helix 2024
  • Company profile in One Nucleus Annual Review 2024 or similar publication

Draft Programme (subject to change):

Monday 22 April 2024

  • 13.00 flight LHR – BOS
  • 15.45 – Land BOS and transfer to hotel
  • Team dinner/drinks at hotel/nearby

Tuesday 23 April 2024

  • Morning Session – Introduction to MA Ecosystem and Navigating the Landscape Hosted by BioMed Realty
  • An overview of the MA life sciences sector
  • Support available to UK companies seeking to do business in MA
  • Networking Lunch Hosted by RSM
  • Afternoon Session – Best Operational Strategies Hosted by Cushman & Wakefield
  • Facilities Leasing
  • Recruitment
  • Reporting Compliance
  • Networking Reception Hosted by Cushman & Wakefield
  • Dinner

Wednesday 24 April 2024

  • Morning Session – ​IP Strategy Hosted by Wolf Greenfield
    • IP basics and issues associated with operational strategies
    • Issues surrounding joint IP and strategy associated with agreements
  • Networking Lunch Hosted by Wolf Greenfield
  • Afternoon Session – ​Raising Investment Hosted by Gunderson Dettmer
    • Financing landscape
    • Business Model and Value Proposition
    • Terms Sheets
    • Due Diligence
  • Networking Reception Hosted by Gunderson Dettmer
  • Dinner

Thursday 25 April 2024

  • Attend MassBio Align Summit
  • Depart BOS for LHR flight at 22.10


  • Competition launch – 7 December 2023
  • One Nucleus Life Science Dinner – 31 January 2024
  • Competition close and end of submission period – 7 February 2024
  • Presentations Day – 20 February 2024
  • Winners announced – 22 February 2024
  • Pre Bootcamp Activity - Dates in March tbc
  • One Nucleus Awards Dinner – 21 March 2024
  • Bootcamp dates in Boston, MA –  22 April to 25 April 2024
  • Feedback on key messages at ON Helix – 4 July 2024

Entry Criteria:

  • Innovative new medicine discovery programmes or platforms
  • Incorporated entity
  • Clear ambition to engage with MA ecosystem

We are no longer accepting entries for this year. 

Judging Panel:

UK Based
Malcolm Bates, Partner, Goodwin UK, One Nucleus Board Member
Ro Gardner, VP Operations, Microbiotica and Head of Operations, Actigen, One Nucleus Board Member
Jon Green, Director, Unity Campus, Chairman of One Nucleus
Stuart Hendry, Chief Executive Officer, HecoAnalytics Ltd, One Nucleus Board Member
Penny James, Chief Operating Officer, BioPharmaceuticals R&D AstraZeneca, One Nucleus Board Member
Andrew Muncey - Chief Operating Officer, Artios Pharma Ltd, One Nucleus Board Member
Professor Alan M. Palmer, Chief Executive Officer, Elixa MediScience, One Nucleus Board Member
Prashant Shah, co-CEO and co-founder of o2h, One Nucleus Board Member
Judit Molnar, VP and Head of Early Development, tranScrip, One Nucleus Board Member
Emily Hayes, Partner, Mewburn Ellis LLP
Ross McNaughton, Partner, Corporate Technology and Life Sciences, Taylor Wessing
Russell Oakley, Associate Director, Business Development, CK Group (part of the Talentmark group)
Michael Aston, Partner, Head of Life Sciences, Cushman & Wakefield
Laragh Jeanroy, Managing Partner, RSM East Anglia

US Based
Oona Johnstone, Shareholder and Patent Attorney, Wolf Greenfield
Ted Agne, President, Communications Strategy Group Inc
Chris Ilsley, President & CEO, InnoVenture Labs
Emilie Braun, Senior Director, Business Development & Licensing, Mass General Brigham Innovation
Joel Berniac, President & Founder, BioFuturis
Ben Bradford, Head of External Affairs, MassBio

Matthew Clark, British Consulate-General Boston - Life Sciences & Healthcare Lead, Department for Business and Trade

Further Information:
For enquiries or additional information, contact